Safety of a fixed-dose combination of artesunate and amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in real-life conditions of use in Côte d’Ivoire

Artesunate/Amodiaquine-Induced Acute Extrapyramidal Reactions in Children and Younger Adults: Case Series Assessment

(2016) Mulugeta Russom et al.   DRUG SAFETY

Feasibility and cost of using mobile phones for capturing drug safety information in peri-urban settlement in Ghana: a prospective cohort study of patients with uncomplicated malaria

(2015) Vida Ami Kukula et al.   MALARIA JOURNAL

Prospective observational study to evaluate the clinical safety of the fixed-dose artemisinin-based combination Eurartesim® (dihydroartemisinin/piperaquine), in public health facilities in Burkina Faso, Mozambique, Ghana, and Tanzania

(2015) Rita Baiden et al.   MALARIA JOURNAL

Profile of Adverse Events in Patients Receiving Treatment for Malaria in Urban Ghana: A Cohort-Event Monitoring Study

(2014) Alexander N. O. Dodoo et al.   DRUG SAFETY

Efficacy and Safety of Fixed-Dose Artesunate-Amodiaquine vs. Artemether-Lumefantrine for Repeated Treatment of Uncomplicated Malaria in Ugandan Children

(2014) Adoke Yeka et al.   PLoS One

Artesunate- and Amodiaquine-Associated Extrapyramidal Reactions

(2013) John McEwen   DRUG SAFETY

Safety of Artemisinin-Based Combination Therapies in Nigeria: A Cohort Event Monitoring Study

(2013) Peter Usman Bassi et al.   DRUG SAFETY

Malaria

(2013) Nicholas J White et al.   LANCET

Usefulness of Plasmodium falciparum-specific rapid diagnostic tests for assessment of parasite clearance and detection of recurrent infections after artemisinin-based combination therapy

(2013) Berit Aydin-Schmidt et al.   MALARIA JOURNAL

Safety monitoring of artemisinin combination therapy through a national pharmacovigilance system in an endemic malaria setting

(2013) Sylla Thiam et al.   MALARIA JOURNAL

Early parasitological response following artemisinin-containing regimens: a critical review of the literature

(2013) Debashish Das et al.   MALARIA JOURNAL

Anti-malarial drug safety information obtained through routine monitoring in a rural district of South-Western Senegal

(2012) Philippe Brasseur et al.   MALARIA JOURNAL

Efficacy of fixed-dose combination artesunate-amodiaquine versus artemether-lumefantrine for uncomplicated childhood Plasmodium falciparum malaria in Democratic Republic of Congo: a randomized non-inferiority trial

(2012) Emmanuelle Espié et al.   MALARIA JOURNAL

Oral Artesunate-Amodiaquine and Artemether-Lumefantrine in the Treatment of Uncomplicated Hyperparasitaemic Plasmodium falciparum Malaria in Children

(2011) G. O. Gbotosho et al.   JOURNAL OF TROPICAL PEDIATRICS

An open randomized clinical trial in comparing two artesunate-based combination treatments on Plasmodium falciparum malaria in Nigerian children: artesunate/sulphamethoxypyrazine/pyrimethamine (fixed dose over 24 hours) versus artesunate/amodiaquine (fixed dose over 48 hours)

(2011) Idowu Ayede et al.   MALARIA JOURNAL

Exposure to anti-malarial drugs and monitoring of adverse drug reactions using toll-free mobile phone calls in private retail sector in Sagamu, Nigeria: implications for pharmacovigilance

(2011) Ahmed A Adedeji et al.   MALARIA JOURNAL

Innovative public-private partnerships to maximize the delivery of anti-malarial medicines: lessons learned from the ASAQ Winthrop experience

(2011) François Bompart et al.   MALARIA JOURNAL

Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial

(2011) Jean-Louis A Ndiaye et al.   MALARIA JOURNAL

Experience of safety monitoring in the context of a prospective observational study of artemether-lumefantrine in rural Tanzania: lessons learned for pharmacovigilance reporting

(2010) Abdunoor M Kabanywanyi et al.   MALARIA JOURNAL

Methods for Causality Assessment of Adverse Drug Reactions

(2009) Taofikat B Agbabiaka et al.   DRUG SAFETY

Comparison of Sulfadoxine‐Pyrimethamine, Unsupervised Artemether‐Lumefantrine, and Unsupervised Artesunate‐Amodiaquine Fixed‐Dose Formulation for UncomplicatedPlasmodium falciparumMalaria in Benin: A Randomized Effectiveness Noninferiority Trial

(2009) Jean‐François Faucher et al.   JOURNAL OF INFECTIOUS DISEASES

The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Plasmodium falciparum

(2009) Sodiomon B Sirima et al.   MALARIA JOURNAL

Pattern of drug utilization for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin-combination therapy

(2009) Alexander NO Dodoo et al.   MALARIA JOURNAL

Randomized, multicentre assessment of the efficacy and safety of ASAQ – a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria

(2009) Jean Ndiaye et al.   MALARIA JOURNAL